Comprehensively reviews database establishment, computational tools, experimental strategies, and biochemistry/crystallographic studies of metalloenzymes and their drug discovery applications.
Edited by:
Guo-Bo Li (Sichuan University China)
Imprint: Blackwell Verlag GmbH
Country of Publication: Germany
Edition: 2 Volume Set
Dimensions:
Height: 244mm,
Width: 170mm,
ISBN: 9783527354245
ISBN 10: 3527354247
Pages: 544
Publication Date: 07 January 2026
Audience:
Professional and scholarly
,
Undergraduate
Format: Hardback
Publisher's Status: Forthcoming
1. Advances in Database and Computational Tools for Drug Discovery Targeting Metalloenzymes 2. Metal-Binding Pharmacophores for Metalloenzyme Drug Discovery 3. Multiscale Computational Approaches in Metal?Ligand Interactions in Drug Design 4. Modelling Metalloenzyme Catalytic Mechanisms by QM/MM Calculations 5. Metalloenzyme-specific Scoring Function 6. Experimental Strategies in Metalloenzyme Mechanism Study and Drug Discovery 7. Structural and Chemical Biology of 2-Oxoglutarate-dependent Oxygenases 8. MBL-fold Nucleases in DNA Repair and Drug Discovery 9. Regulatory, Inhibitory Mechanisms and Drug Discovery of Tryptophan/ Indoleamine 2,3-Dioxygenase (TDO/IDO) 10. Histone Deacetylase Inhibitor Discovery 11. Drug Discovery Targeting Phosphodiesterases 12. Metalloenzymes in RNA metabolism 13. Targeting Metallo-¿-lactamases to Combine Antibiotic Resistance 14. Structural Insights and Drug Discovery into Cytochrome P450 Enzymes 15. Drug Discovery Targeting Viral Metalloenzymes 16. Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors 17. Drug Discovery Targeting Membrane Metalloenzyme CD73 18. Targeting Carbonic Anhydrases for Disease Treatment 19. Bacterial LpxC Inhibitor Discovery 20. Drug Discovery Targeting Human and Fungal CYP51 21. Targeting Autotaxin (ATX) for Therapeutic Intervention
Guo-Bo Li is Professor in the Department of Medicinal Chemistry at Sichuan University, China. His research group now focuses on development of new computational tools, new data resources and new web servers to assist basic science and drug discovery research particularly targeting metalloenzymes, and development of new chemical probes, new hits/leads or drug candidates to exploit metalloenzyme biological/pathological roles and therapeutical potentials.